The invention further comprises a pharmaceutical composition comprising an antibody of the invention or an antigen binding fragment thereof, {HEAD ~ a nucleic acid molecule} of {TAIL ~ the invention}, or an immunogenic polypeptide of the invention, and a pharmaceutically acceptable diluent or carrier 
of
The invention further comprises a pharmaceutical composition comprising an antibody of the invention or an antigen binding fragment thereof , { HEAD ~ a nucleic acid molecule } of { TAIL ~ the invention } , or an immunogenic polypeptide of the invention , and a pharmaceutically acceptable diluent or carrier
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD HEAD REL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH